Understanding CAR-T therapy in myeloma: 1 cell at a time

Blood Adv. 2024 Jul 9;8(13):3560-3561. doi: 10.1182/bloodadvances.2024013292.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Immunotherapy, Adoptive* / methods
  • Multiple Myeloma* / therapy
  • Receptors, Chimeric Antigen*
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism

Substances

  • Receptors, Chimeric Antigen